◄ back to all posts

EBS: Emergent Biosolutions Inc Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4,122.76
Enterprise Value ($M) 4,420.76
Book Value ($M) 1,447.00
Book Value / Share 27.15
Price / Book 2.85
NCAV ($M) -240.30
NCAV / Share -4.51
Price / NCAV -17.16

Profitability (mra)
Return on Invested Capital (ROIC) 0.13
Return on Assets (ROA) 0.13
Return on Equity (ROE) 0.28

Liquidity (mrq)
Quick Ratio 2.31
Current Ratio 3.11

Balance Sheet (mrq) ($M)
Current Assets 1,195.90
Assets 2,883.20
Liabilities 1,436.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 433.80
Net Income 305.10
Earnings Per Share Diluted 5.67
Earnings Per Share Basic 5.79

Cash Flow Statement (mra) ($M)
Cash From Operations 536.00
Cash from Investing -151.00
Cash from Financing -151.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-10 13G/A BlackRock Inc. 10.10 0.00
02-12 13G Neuberger Berman Group LLC 6.06
02-10 13G/A Vanguard Group Inc 9.04 2.64
2019-02-08 13G/A Dimensional Fund Advisors Lp 3.32 -24.79
2016-02-12 13G/A Broadfin Capital, LLC 1.70
2016-01-11 13G/A Bank of New York Mellon Corp 4.81 274.63
2015-11-13 13G/A Loomis Sayles & Co L P 2.20
2013-02-14 13G/A Scopia Capital Management Lp 0.00
2013-01-29 13G/A Royce & Associates Lp 0.37

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-02-19 10-K Annual Report – 10-K
2020-11-06 10-Q Quarterly Report – 10-Q
2020-07-31 10-Q Quarterly Report – 10-Q
2020-05-01 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-04-09 168,311 979,948 17.18
2021-04-08 143,946 885,488 16.26
2021-04-07 179,110 1,310,775 13.66
2021-04-06 179,896 1,334,900 13.48

(click for more detail)

(click for list of largest short owners)

Similar Companies
BHVN – Biohaven Pharmaceutical Holding Co Ltd BMY – Bristol-Myers Squibb Co
CTLT – Catalent Inc ELAN – Elanco Animal Health Inc
ELAT – Elanco Animal Health Incorporated 5.00% Tangible Equity Units


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

401 K